Susceptibility to β-lactams in β-hemolytic streptococci
Group A (GAS), B (GBS), C (GCS) and G (GGS) β-hemolytic streptococci are important human pathogens. They cause infections of different severity and frequency. Nowadays, after 70 years of use, penicillin is still universally active against GAS, GCS and GGS. However, therapeutic failures have been rec...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | INPR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_03257541_v_n_p_Bonofiglio |
Aporte de: |
id |
todo:paper_03257541_v_n_p_Bonofiglio |
---|---|
record_format |
dspace |
spelling |
todo:paper_03257541_v_n_p_Bonofiglio2023-10-03T15:24:24Z Susceptibility to β-lactams in β-hemolytic streptococci Bonofiglio, L. Gagetti, P. García Gabarrot, G. Kaufman, S. Mollerach, M. Toresani, I. Vigliarolo, L. von Specht, M. Lopardo, H.A. Penicillin Streptococcus agalactiae Streptococcus dysgalactiae subsp. equisimilis Streptococcus pyogenes Susceptibility β-Lactams Group A (GAS), B (GBS), C (GCS) and G (GGS) β-hemolytic streptococci are important human pathogens. They cause infections of different severity and frequency. Nowadays, after 70 years of use, penicillin is still universally active against GAS, GCS and GGS. However, therapeutic failures have been recorded in 2-28% of pharyngitis cases (median: 12%) attributable to different causes. By contrast, some GBS with reduced susceptibility to penicillin have been described, especially in Japan. In this group of bacteria, it is important to highlight that confirmation by reference methods is mandatory when decreased susceptibility to penicillin is suspected as well as checked for the detection of the mechanisms involved. Los estreptococos β-hemolíticos de los grupos A (GAS), B (GBS), C (GCS) y G (GGS) son importantes patógenos humanos. Ellos producen infecciones de diversa gravedad y frecuencia. Aún después de más de 70 años de uso, la penicilina sigue siendo activa in vitro frente al 100% de los GAS, GCS y GGS. No obstante se han producido fallas terapéuticas entre el 2-28% de los casos de faringitis (media: 12%), atribuibles a diversas causas. En cambio se han descrito aislados de GBS con sensibilidad reducida a la penicilina, especialmente en Japón. Es importante que toda sospecha de sensibilidad disminuida a la penicilina en este grupo de bacterias sea confirmada por los métodos de referencia y comprobada mediante la detección de los mecanismos involucrados. © 2017 Asociación Argentina de Microbiología. INPR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03257541_v_n_p_Bonofiglio |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
Penicillin Streptococcus agalactiae Streptococcus dysgalactiae subsp. equisimilis Streptococcus pyogenes Susceptibility β-Lactams |
spellingShingle |
Penicillin Streptococcus agalactiae Streptococcus dysgalactiae subsp. equisimilis Streptococcus pyogenes Susceptibility β-Lactams Bonofiglio, L. Gagetti, P. García Gabarrot, G. Kaufman, S. Mollerach, M. Toresani, I. Vigliarolo, L. von Specht, M. Lopardo, H.A. Susceptibility to β-lactams in β-hemolytic streptococci |
topic_facet |
Penicillin Streptococcus agalactiae Streptococcus dysgalactiae subsp. equisimilis Streptococcus pyogenes Susceptibility β-Lactams |
description |
Group A (GAS), B (GBS), C (GCS) and G (GGS) β-hemolytic streptococci are important human pathogens. They cause infections of different severity and frequency. Nowadays, after 70 years of use, penicillin is still universally active against GAS, GCS and GGS. However, therapeutic failures have been recorded in 2-28% of pharyngitis cases (median: 12%) attributable to different causes. By contrast, some GBS with reduced susceptibility to penicillin have been described, especially in Japan. In this group of bacteria, it is important to highlight that confirmation by reference methods is mandatory when decreased susceptibility to penicillin is suspected as well as checked for the detection of the mechanisms involved. Los estreptococos β-hemolíticos de los grupos A (GAS), B (GBS), C (GCS) y G (GGS) son importantes patógenos humanos. Ellos producen infecciones de diversa gravedad y frecuencia. Aún después de más de 70 años de uso, la penicilina sigue siendo activa in vitro frente al 100% de los GAS, GCS y GGS. No obstante se han producido fallas terapéuticas entre el 2-28% de los casos de faringitis (media: 12%), atribuibles a diversas causas. En cambio se han descrito aislados de GBS con sensibilidad reducida a la penicilina, especialmente en Japón. Es importante que toda sospecha de sensibilidad disminuida a la penicilina en este grupo de bacterias sea confirmada por los métodos de referencia y comprobada mediante la detección de los mecanismos involucrados. © 2017 Asociación Argentina de Microbiología. |
format |
INPR |
author |
Bonofiglio, L. Gagetti, P. García Gabarrot, G. Kaufman, S. Mollerach, M. Toresani, I. Vigliarolo, L. von Specht, M. Lopardo, H.A. |
author_facet |
Bonofiglio, L. Gagetti, P. García Gabarrot, G. Kaufman, S. Mollerach, M. Toresani, I. Vigliarolo, L. von Specht, M. Lopardo, H.A. |
author_sort |
Bonofiglio, L. |
title |
Susceptibility to β-lactams in β-hemolytic streptococci |
title_short |
Susceptibility to β-lactams in β-hemolytic streptococci |
title_full |
Susceptibility to β-lactams in β-hemolytic streptococci |
title_fullStr |
Susceptibility to β-lactams in β-hemolytic streptococci |
title_full_unstemmed |
Susceptibility to β-lactams in β-hemolytic streptococci |
title_sort |
susceptibility to β-lactams in β-hemolytic streptococci |
url |
http://hdl.handle.net/20.500.12110/paper_03257541_v_n_p_Bonofiglio |
work_keys_str_mv |
AT bonofigliol susceptibilitytoblactamsinbhemolyticstreptococci AT gagettip susceptibilitytoblactamsinbhemolyticstreptococci AT garciagabarrotg susceptibilitytoblactamsinbhemolyticstreptococci AT kaufmans susceptibilitytoblactamsinbhemolyticstreptococci AT mollerachm susceptibilitytoblactamsinbhemolyticstreptococci AT toresanii susceptibilitytoblactamsinbhemolyticstreptococci AT vigliarolol susceptibilitytoblactamsinbhemolyticstreptococci AT vonspechtm susceptibilitytoblactamsinbhemolyticstreptococci AT lopardoha susceptibilitytoblactamsinbhemolyticstreptococci |
_version_ |
1807322646754361344 |